Increased skin cancer mortality in chile beyond the effect of ageing: Temporal analysis 1990 to 2005

Acta Dermato-Venereologica

Volumn 90, Issue 2, 2010, Pages 141-146

  Alonso, Faustino T ^a   Garmendia, Maria Luisa ^a   Bogado, Mariana E ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Chile; Mortality; Skin neoplasms

Indexed keywords

AGED; AGING; ARTICLE; CANCER MORTALITY; CHILE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILE; FEMALE; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; POPULATION SURVEILLANCE; REGRESSION ANALYSIS; RESIDENCE CHARACTERISTICS; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; SKIN NEOPLASMS; TIME FACTORS;

EID: 77950282804     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0787     Document Type: Article

References (55)

1. World Health Organization. WHO / Ultraviolet Radiation and Health - FAQs. Intersun Programme 2007 06/22/2007 [cited 2008 November 25]. Available from: http://www.who.int/uv/faq/skincancer/en/index1.html.
2. World Health Organization. Global burden of disease and risk factors: 2002. Geneva: WHO, 2003.
3. Marin PP. [The situation of the elderly in Chile]. Rev Med Chil 1997; 125: 1207-1212 (in Spanish).
4. Szot Meza J. [Evolution of skin cancer mortality in Chile: 1980-2000]. Revista Chilena de Dermatología 2003; 19: 173-177 (in Spanish).
5. Valdés R, Martic A, Muñoz O, López C, Valdivia G. [Skin Cancer mortality trends in Chile, 1987-1998.] Revista Chilena de Salud Pública 2002; 6: 21-26 (in Spanish).
6. Zemelman V, Garmendia ML, Kirschbaum A. Malignant melanoma mortality rates in Chile (1988-1998). Int J Dermatol 2002; 41: 99-103.
7. Ferreccio C, Sancha AM. Arsenic exposure and its impact on health in Chile. J Health Popul Nutr 2006; 24: 164-175.
8. Borgono JM, Vicent P, Venturino H, Infante A. Arsenic in the drinking water of the city of Antofagasta: epidemiological and clinical study before and after the installation of a treatment plant. Environ Health Perspect 1977; 19: 103-105.
9. Cabrera S, Bozzo S, Fuenzalida H. Variations in UV radiation in Chile. J Photochem Photobiol B 1995; 28: 137-142.
10. Mathers C. Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull WHO 2005; 83: 171-177.
11. Nunez FM, Icaza NM. [Quality of mortality statistics in Chile, 1997-2003]. Rev Med Chil 2006; 134: 1191-1196 (in Spanish).
12. National Institute of Statistics of Chile. [Chilean population projections 1990-2025]. 2002 ed. National Institute of Statistics of Chile, Santiago, Chile, 2002 (in Spanish).
13. Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJ, Lozano R, Inoue M. Age standardization of rates: a new WHO standard. Geneva: OMS, 2001.
14. Panamerican Health Organisation (PAHO). Standardization: A classic epidemiological method for the comparison of rates. Epidemiol Bull 2002; 23: 9-12.
15. Prais SJ, Winsten. CB. Trend estimators and serial correlation. Cowles Commission Discussion Paper No 383. Chicago: University of Chicago; 1954.
16. Bence JR. Analysis of short time series: correcting for autocorrelation. Ecology 1995; 76: 628-639.
17. StataCorp. Stata Statistical Software: Release 10. College Station, TX: StataCorp LP, 2007, http://www.stata.com/support/faqs/res/cite.html.
18. Environmental System Research Institute Inc. ArcView 3.3. Environmental System Research Institute. Redlands, CA, USA, 1992-1999.
19. Zemelman V, Roa J, Tagle SR, Valenzuela CY. Malignant melanoma in Chile: an unusual distribution of primary sites in men from low socioeconomic strata. Clin Exp Dermatol 2006; 31: 335-338.
20. Lens MB, Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 2004; 150: 179-185.
21. Nieto A, Ruiz-Ramos M, Abdel-Kader L, Conde M, Camacho F. Gender differences in rising trends in cutaneous malignant melanoma in Spain, 1975-1998. Br J Dermatol 2003; 148: 110-116.
22. de Vries E, Schouten LJ, Visser O, Eggermont AM, Coebergh JW. Rising trends in the incidence of and mortality from cutaneous melanoma in the Netherlands: a Northwest to Southeast gradient? Eur J Cancer 2003; 39: 1439-1446.
23. Jacobo Parada R, Pineda Corona B, León Dorantes G. [Malignant melanoma: epidemiological profile in Mexico]. Gaceta Sociedad Mexicana de Oncología 2003: 2; 17-22 (in Spanish).
24. Severi G, Giles GG, Robertson C, Boyle P, Autier P. Mortality from cutaneous melanoma: evidence for contrasting trends between populations. Br J Cancer 2000; 82: 1887-1891.
25. La Vecchia C, Lucchini F, Negri E, Levi F. Recent declines in worldwide mortality from cutaneous melanoma in youth and middle age. Int J Cancer 1999; 81: 62-66.
26. Cohn-Cedermark G, Mansson-Brahme E, Rutqvist LE, Larsson O, Johansson H, Ringborg U. Trends in mortality from malignant melanoma in Sweden, 1970-1996. Cancer 2000; 89: 348-355.
27. Hannuksela-Svahn A, Pukkala E, Karvonen J. Basal cell skin carcinoma and other nonmelanoma skin cancer in Finland from 1956 through 1995. Arch Dermatol 1999; 135: 781-786.
28. Stang A, Jockei KH. Changing patterns of skin melanoma mortality in West Germany from 1968 through 1999. Ann Epidemiol 2003; 13: 436-442.
29. Lewis KG, Weinstock MA. Trends in nonmelanoma skin cancer mortality rates in the United States, 1969 through 2000. J Invest Dermatol 2007; 127: 2323-2327.
30. Mansson-Brahme E. Melanoma epidemiology in Sweden. Arch Oncol 2005; 13: 69-71.
31. American Cancer Society. Skin Cancer: ACS; 2004 1/05/08.
32. Australian Institute of Health and Welfare (AIHW). State & territories GRIM (General Record of Incidence of Mortality). Australian Institute of Health and Welfare, 2005; Canberra, Australia.
33. Petcheneshsky T, Panero MS, Rivero SI. [Mortality by malignant melanoma and non-melanoma skin cancer in Argentina (1980-2000)]. I Congreso Latinoamericano de Radiación Ultravioleta: su medición y sus efectos, Buenos Aires, 2002 (in Spanish).
34. Swartout HO, Webster RG. To what degree are mortality statistics dependable? Am J Public Health Nations Health 1940; 30: 811-815.
35. Percy C, Stanek E 3rd, Gloeckler L. Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health 1981; 71: 242-250.
36. Lewis KG, Weinstock MA. Nonmelanoma skin cancer mortality (1988-2000): the Rhode Island follow-back study. Arch Dermatol 2004; 140: 837-842.
37. Miller JG, Mac Neil S. Gender and cutaneous melanoma. Br J Dermatol 1997; 136: 657-665.
38. Balzi D, Carli P, Geddes M. Malignant melanoma in Europe: changes in mortality rates (1970-1990) in European Community countries. Cancer Causes Control 1997; 8: 85-92.
39. de Vries E, Tyczynski J, Parkin DM. Cutaneous Malignant Melanoma in Europe. In: European Network of Cancer Registries, editor. ENCR cancer fact sheets. Lyon: International Agency for Research on Cancer, 2003.
40. Boyle P, Doré JF, Autier P, Ringborg U. Cancer of the skin: a forgotten problem in Europe. Ann Oncol 2004; 15: 5-6.
41. Zemelman V, Roa V, Díaz C, Araya I, Zamalloa G, Faúndez E. [Increase of the incidence of the skin cancer in public hospitals of the Región Metropolitana 1992-1998]. Revista Chilena de Dermatología 2001; 17: 180-185 (in Spanish).
42. Abarca JF, Casiccia CC. Skin cancer and ultraviolet-B radiation under the Antarctic ozone hole: southern Chile 1987-2002. Photodermatol Photoimmunol Photomed 2002; 18: 294-302.
43. Vallebuona C, Bertran E, Moraga AM, Goycolea M. [Chilean Cancer Registries]. [National Epidemiology Meeting 2006]. Santiago, Chile: Gobierno de Chile, Ministro de Salud; 2006, p. 16-20 (in Spanish).
44. Enviromental Protection Agency. Arsenic in drinking water. 2007 03/26/2007 [cited 2008 05/04/2008]; Available from: http://www.epa.gov/ safewater/arsenic/basicinformation.html
45. Ferreccio C, Gonzalez C, Milosavjlevic V, Marshall G, Sancha AM, Smith AH. Lung cancer and arsenic concentrations in drinking water in Chile. Epidemiology 2000; 11: 673-679.
46. Marshall G, Ferreccio C, Yuan Y, Bates MN, Steinmaus C, Selvin S, et al. Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water. J Natl Cancer Inst 2007; 99: 920-928.
47. Smith AH, Goycolea M, Haque R, Biggs ML. Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am J Epidemiol 1998; 147: 660-669.
48. World Health Organization. Guidelines for drinking-water quality, third edition, incorporating first addendum. Geneva: WHO, 2006.
49. Gawkrodger DJ. Occupational skin cancers. Occup Med (Lond) 2004; 54: 458-463.
50. Zemelman V, Araya I, Rojas H, et al. [Skin cancer awareness campaign organized by Dermatologic Service of Universidad de Chile Clinical Hospital, Exposol 2003]. Revista Chilena de Dermatología 2005; 21: 85-90 (in Spanish).
51. Aviles JA, Lazare P, Lecona M. [Epidemiology and survival of cutaneous melanoma in Spain: A report of 552 cases (1994-2003)]. Rev Clin Esp 2006; 206: 319-325.
52. Lasithiotakis KG, Leiter U, Eigentier T, Breuninger H, Metzler G, Meier F, et al. Improvement of overall survival of patients with cutaneous melanoma in Germany, 1976-2001: which factors contributed? Cancer 2007; 109: 1174-1182 (in Spanish).
53. Balzi D, Carli P, Giannotti B, Paci E, Buiatti E. Cutaneous melanoma in the Florentine area, Italy: incidence, survival and mortality between 1985 and 1994. Eur J Cancer Prev 2003; 12: 43-48.
54. Karjalainen S, Hakulinen T. Survival and prognostic factors of patients with skin melanoma. A regression-model analysis based on nationwide cancer registry data. Cancer 1988; 62: 2274-2280.
55. McMullen EA, Kee F, Patterson CC, Gavin AT, Dolan OM. Improved survival for melanoma in Northern Ireland: a comparison of two 5-year periods (1984-1988 and 1994-98). Br J Dermatol 2004; 151: 587-593.